Mazen A. Juratli: Platelet-Derived Extracellular Vesicles as Potential Predictors of Survival in Liver Cancer
Mazen A. Juratli, Professor and Senior Consultant in Visceral Surgery at the University Hospital Münster, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in OAE Journals, adding:
“New publication: Platelet-derived extracellular vesicles and post-ablation survival in HCC
Our prospective cohort study is now out in: Extracellular Vesicles and Circulating Nucleic Acids
We profiled plasma extracellular vesicles (EVs) in 53 patients (38 HCC) before and 1 h after microwave ablation, alongside cytokines and T-cell subsets.
Key findings:
HCC patients showed a distinct EV signature with liver cancer stem cell-associated markers (CD133, CD44, CD24).
Four platelet-adhesion EV markers (CD29, CD41b, CD42a, CD62P) were higher before ablation in HCC patients who later died.
Thank you to all co-authors!”
Title: Platelet-derived extracellular vesicles and post-ablation survival in hepatocellular carcinoma: a prospective cohort study
Authors: Thomas Vogl, Ibrahim Büdeyri, Wenyi Gu, Elsie Oppermann, Lisa Ysermann, Dhruvajyoti Roy, Nicola Pollmann, Nour-Eldin Nour-Eldin, Katrin Eichler, Benjamin Struecker, Michael Praktiknjo, Kerstin Menck, Jonel Trebicka, Andreas Pascher, Ruchi Bansal, Wolf Bechstein, Markus Zimmermann, Mazen Juratli
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 24, 2026, 14:28Satyam Arora: Umbilical Cord Blood for Neonatal Transfusions
-
Oct 24, 2026, 13:24Amelia Carro Hevia: Ischaemic Stroke Risk in Atrial Flutter vs Atrial Fibrillation
-
Oct 24, 2026, 12:27Emeka Patrick Chukwuka: Ferritin Falls First – Iron Deficiency Before Anaemia
-
Oct 24, 2026, 11:57Priyanka Kandalgaokar: Sharing India’s Patient Advocacy Journey at MPN Horizon 2026
-
Oct 24, 2026, 11:40Uli Schotten: Coagulation Factors May Influence Cardiac Remodelling
-
Oct 24, 2026, 11:20Edward Lee Carter: Anticoagulation After Intracranial Hemorrhage – Encouraging Data, but an Unresolved Tradeoff
-
Oct 24, 2026, 11:16Aram Hovhannisyan: New Evidence on CAT from the THEO Study
-
Oct 24, 2026, 10:49Shahram Kordasti: Investigating Novel Immune Targets in MPN
-
Oct 24, 2026, 10:32Amber Yates: A Major Milestone for the RISE UP Phase 3 Study